Search results for: 'android ed poc terminals forecast 2024'

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

This study examines and analyses the European market for medical grade PCs, MCAs, and bedside terminals. The research service presents the market definition and its dynamics. It examines the market in terms of various factors that influence the market and also discusses the competitive trends along with the geographical trends prevailing in the mar...

Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, ear...

There is a growing demand for mobile imaging equipment in low and middle-income countries due to the limited financial resources to procure, operate, and maintain expensive medical imaging equipment. Other challenges include irregular power supply, poor network connectivity, inadequate site infrastructure, and delays because of the geographical dis...

Smartphone-based point-of-care (POC) diagnostics are rapidly emerging as medical diagnostics, enabling remote or self-monitoring tools for general wellness and a range of health conditions. Smartphones enable low-cost, rapid, and handy POC diagnostics. Intrinsic sensors of smartphones or extrinsic sensing devices working with intelligent data analy...

This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, sm...

In this analysis, Frost & Sullivan provides critical insights into the biotech M&A and venture capital (VC) investment, highlighting the drivers, challenges, predictions, and major trends in the biotech segment. This analysis also identifies actionable growth opportunities for industry participants to leverage. To understand the trend outlook fo...

05 Sep 2019  |  Global  |  Market Research

Digital Transformation of the Global Medtech Industry, Forecast to 2024

Growth Opportunities to Boost Revenue in this Slowing Industry by an Additional $240 Billion by 2024

Infographics

×

Key Issues Addressed

The medtech industry’s revenue growth is expected to gradually dip beyond 2020, from a year-on-year growth of about 5.7Percentage in 2020 to 5.3Percentage in 2024. The industry is already addressing this as well as several other challenges such as the changing device ecosystem, shifting competitive focus, and the invasion by technology companies. M...

Femtech is an emerging term and, as is the case with most new concepts, is poorly understood. While some relate Femtech only with products unique to the female anatomy (including consumer products), others dismiss it as just another term for a group of existing solutions. Frost & Sullivan believes it is a unique space and a place for new growth opp...